{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T14:05:01Z","timestamp":1762437901986,"version":"build-2065373602"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVES:<\/jats:title>\n                    <jats:p>Secondary infections are a common occurrence in critically ill COVID-19 patients. These are difficult to identify, and antibiotic usage is high in this population. Identification of biomarkers for secondary infections would help to ensure antibiotics are being utilized only for patients who require them. This study sought to identify a panel of biomarkers capable of distinguishing critically ill COVID-19 patients with and without secondary infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DESIGN:<\/jats:title>\n                    <jats:p>A multicenter retrospective cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SETTING:<\/jats:title>\n                    <jats:p>Three critical care units in Scotland, United Kingdom.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PATIENTS:<\/jats:title>\n                    <jats:p>One hundred five patients admitted to critical care with COVID-19, and 49 healthy volunteer controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>INTERVENTIONS:<\/jats:title>\n                    <jats:p>None.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n                    <jats:p>Serial blood samples were obtained from critically ill COVID-19 patients with and without confirmed secondary infections, and a single sample was collected from healthy volunteers to provide baseline metabolic profiles. Metabolomic analysis was performed using liquid chromatography-mass spectrometry, and metabolites that were significantly different between patients with and without secondary infections were identified. Additionally, metabolites capable of distinguishing Gram-positive from Gram-negative organisms were also investigated. Forty patients developed a secondary infection during the study period. A significant increase in metabolites creatine and 2-hydroxyisovalerylcarnitine, and a significant reduction in S-methyl-L-cysteine were detected in patients with secondary infections. This metabolite panel could identify patients with secondary infections with an area under the curve (AUC) of 0.83 (95% CI, 0.68\u20130.97). Metabolites differentiating Gram-positive and Gram-negative infections included betaine, N(6)-methyllysine, and phosphatidylcholines (PCs; 38:6), PC(38:4), PC(40:6), and PC(36:4) with an AUC of 0.88 (95% CI, 0.68\u20131.0).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Metabolomic profiling of critically ill COVID-19 shows promise for identification of novel biomarkers for secondary infections. Larger validation studies will help to confirm these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cce.0000000000001336","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T14:00:15Z","timestamp":1762437615000},"page":"e1336","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Metabolomics for the Diagnosis of Secondary Infections in Critically Ill Patients With COVID-19"],"prefix":"10.1097","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2156-7471","authenticated-orcid":false,"given":"Gordan","family":"McCreath","sequence":"first","affiliation":[{"name":"School of Infection and Immunity, College of Medical, Veterinary, and Life Sciences, University of Glasgow, Glasgow, Scotland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e9ment","family":"Regnault","sequence":"additional","affiliation":[{"name":"College of Medical, Veterinary and Life Sciences Shared Research Facilities, University of Glasgow, Glasgow, Scotland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin J.","family":"Blackburn","sequence":"additional","affiliation":[{"name":"College of Medical, Veterinary and Life Sciences Shared Research Facilities, University of Glasgow, Glasgow, Scotland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00f3n\u00e1n","family":"Daly","sequence":"additional","affiliation":[{"name":"College of Medical, Veterinary and Life Sciences Shared Research Facilities, University of Glasgow, Glasgow, Scotland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alistair T.","family":"Leanord","sequence":"additional","affiliation":[{"name":"School of Infection and Immunity, College of Medical, Veterinary, and Life Sciences, University of Glasgow, Glasgow, Scotland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip D.","family":"Whitfield","sequence":"additional","affiliation":[{"name":"College of Medical, Veterinary and Life Sciences Shared Research Facilities, University of Glasgow, Glasgow, Scotland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Roe","sequence":"additional","affiliation":[{"name":"School of Infection and Immunity, College of Medical, Veterinary, and Life Sciences, University of Glasgow, Glasgow, Scotland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Davidson","sequence":"additional","affiliation":[{"name":"School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm J.","family":"Watson","sequence":"additional","affiliation":[{"name":"School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm A. B.","family":"Sim","sequence":"additional","affiliation":[{"name":"School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"R2-20251106","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study.","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"R3-20251106","doi-asserted-by":"crossref","first-page":"e0247461","DOI":"10.1371\/journal.pone.0247461","article-title":"Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis.","volume":"16","author":"Booth","year":"2021","journal-title":"PLoS One"},{"key":"R4-20251106","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China.","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"R5-20251106","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0140-6736(22)02465-5","article-title":"Past SARS-CoV-2 infection protection against re-infection: A systematic review and meta-analysis.","volume":"401","author":"Stein","year":"2023","journal-title":"Lancet"},{"key":"R6-20251106","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12879-022-07942-x","article-title":"Bacterial co-infection and antibiotic stewardship in patients with COVID-19: A systematic review and meta-analysis.","volume":"23","author":"Calderon","year":"2023","journal-title":"BMC Infect Dis"},{"key":"R7-20251106","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10096-020-04142-w","article-title":"Nosocomial infections associated to COVID-19 in the intensive care unit: Clinical characteristics and outcome.","volume":"40","author":"Bardi","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R8-20251106","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.3346\/jkms.2020.35.e343","article-title":"COVID-19 patients upregulate toll-like receptor 4-mediated inflammatory signaling that mimics bacterial sepsis.","volume":"35","author":"Sohn","year":"2020","journal-title":"J Korean Med Sci"},{"key":"R9-20251106","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/bmjebm-2020-111536","article-title":"Biomarkers and outcomes of COVID-19 hospitalisations: Systematic review and meta-analysis.","volume":"26","author":"Malik","year":"2021","journal-title":"BMJ Evidence-Based Medicine"},{"key":"R10-20251106","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(20)30920-X","article-title":"SARS-CoV-2 and viral sepsis: Observations and hypotheses.","volume":"395","author":"Li","year":"2020","journal-title":"Lancet"},{"key":"R11-20251106","doi-asserted-by":"crossref","first-page":"e000729","DOI":"10.1136\/bmjresp-2020-000729","article-title":"Utility of established prognostic scores in COVID-19 hospital admissions: Multicentre prospective evaluation of CURB-65, NEWS2 and qSOFA.","volume":"7","author":"Bradley","year":"2020","journal-title":"BMJ Open Respir Res"},{"key":"R12-20251106","doi-asserted-by":"crossref","first-page":"547","DOI":"10.7326\/M19-1696","article-title":"Blood culture results before and after antimicrobial administration in patients with severe manifestations of sepsis: A diagnostic study.","volume":"171","author":"Cheng","year":"2019","journal-title":"Ann Intern Med"},{"key":"R13-20251106","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.3390\/jcm10112412","article-title":"Metabolic alterations in sepsis.","volume":"10","author":"Wasyluk","year":"2021","journal-title":"J Clin Med"},{"key":"R14-20251106","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/004982599238047","article-title":"\u201cMetabonomics\u201d: Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data.","volume":"29","author":"Nicholson","year":"1999","journal-title":"Xenobiotica"},{"key":"R16-20251106","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"R17-20251106","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1186\/1471-2105-9-504","article-title":"Highly sensitive feature detection for high resolution LC\/MS.","volume":"9","author":"Tautenhahn","year":"2008","journal-title":"BMC Bioinf"},{"key":"R18-20251106","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1021\/ac2000994","article-title":"PeakML\/mzMatch: A file format, Java library, R library, and tool-chain for mass spectrometry data analysis.","volume":"83","author":"Scheltema","year":"2011","journal-title":"Anal Chem"},{"key":"R19-20251106","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies.","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"R21-20251106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v028.i05","article-title":"Building predictive models in R using the caret package.","volume":"28","author":"Kuhn","year":"2008","journal-title":"J Stat Softw"},{"key":"R22-20251106","article-title":"arm: Data Analysis Using Regression and Multilevel\/Hierarchical Models. CRAN: Contributed Packages 2024.","author":"Gelman"},{"key":"R23-20251106","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jcrc.2017.09.014","article-title":"Metabolomic findings in sepsis as a damage of host-microbial metabolism integration.","volume":"43","author":"Beloborodova","year":"2018","journal-title":"J Crit Care"},{"key":"R24-20251106","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1194\/jlr.P023309","article-title":"Targeted metabolomics for discrimination of systemic inflammatory disorders in critically ill patients.","volume":"53","author":"Schmerler","year":"2012","journal-title":"J Lipid Res"},{"key":"R25-20251106","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/metabo10090359","article-title":"Potential lipid signatures for diagnosis and prognosis of sepsis and systemic inflammatory response syndrome.","volume":"10","author":"Mecatti","year":"2020","journal-title":"Metabolites"},{"key":"R26-20251106","doi-asserted-by":"crossref","first-page":"883628","DOI":"10.3389\/fimmu.2022.883628","article-title":"Landscape of metabolic fingerprinting for diagnosis and risk stratification of sepsis.","volume":"13","author":"Lu","year":"2022","journal-title":"Front Immunol"},{"key":"R27-20251106","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1021\/acs.jproteome.1c00777","article-title":"UPLC\u2013Q-TOF\/MS-based plasma and urine metabolomics contribute to the diagnosis of sepsis.","volume":"21","author":"Guan","year":"2022","journal-title":"J Proteome Res"},{"key":"R28-20251106","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/metabo10020070","article-title":"1H NMR based metabolomics in human sepsis and healthy serum.","volume":"10","author":"Jaurila","year":"2020","journal-title":"Metabolites"},{"key":"R29-20251106","doi-asserted-by":"crossref","first-page":"e0147670","DOI":"10.1371\/journal.pone.0147670","article-title":"Metabolites in blood for prediction of bacteremic sepsis in the emergency room.","volume":"11","author":"Kauppi","year":"2016","journal-title":"PLoS One"},{"key":"R30-20251106","first-page":"1568","article-title":"Exploring plasma metabolomic changes of sepsis: A clinical matching study based on gas chromatography mass spectrometry.","volume":"8","author":"Lin","year":"2020","journal-title":"SSRN Electron J"},{"key":"R31-20251106","doi-asserted-by":"crossref","first-page":"108841","DOI":"10.1016\/j.intimp.2022.108841","article-title":"Identification of metabolomics-based prognostic prediction models for ICU septic patients.","volume":"108","author":"Ding","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"R32-20251106","doi-asserted-by":"crossref","first-page":"9748","DOI":"10.1038\/s41598-017-09619-x","article-title":"Characterization of a metabolomic profile associated with responsiveness to therapy in the acute phase of septic shock.","volume":"7","author":"Cambiaghi","year":"2017","journal-title":"Sci Rep"},{"key":"R33-20251106","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1194\/jlr.M200401-JLR200","article-title":"Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients.","volume":"44","author":"Drobnik","year":"2003","journal-title":"J Lipid Res"},{"key":"R34-20251106","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1097\/CCM.0000000000001740","article-title":"Metabolite profiles in sepsis: Developing prognostic tools based on the type of infection*.","volume":"44","author":"Neugebauer","year":"2016","journal-title":"Crit Care Med"},{"key":"R35-20251106","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13054-014-0729-0","article-title":"Integration of metabolic and inflammatory mediator profiles as a potential prognostic approach for septic shock in the intensive care unit.","volume":"19","author":"Mickiewicz","year":"2015","journal-title":"Crit Care"},{"key":"R36-20251106","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jinf.2015.02.011","article-title":"Lipid mediators of inflammation as novel plasma biomarkers to identify patients with bacteremia.","volume":"70","author":"To","year":"2015","journal-title":"J Infect"},{"key":"R37-20251106","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12967-022-03320-y","article-title":"Integrative analysis of metabolomics and proteomics reveals amino acid metabolism disorder in sepsis.","volume":"20","author":"Chen","year":"2022","journal-title":"J Transl Med"},{"key":"R38-20251106","doi-asserted-by":"crossref","first-page":"7641","DOI":"10.1007\/s00216-016-9845-9","article-title":"Application of LC-MS-based metabolomics method in differentiating septic survivors from non-survivors.","volume":"408","author":"Liu","year":"2016","journal-title":"Anal Bioanal Chem"},{"key":"R39-20251106","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/CCM.0000000000000142","article-title":"Metabolic profiling of serum samples by 1H nuclear magnetic resonance spectroscopy as a potential diagnostic approach for septic shock.","volume":"42","author":"Mickiewicz","year":"2014","journal-title":"Crit Care Med"},{"key":"R40-20251106","doi-asserted-by":"crossref","first-page":"e0121933","DOI":"10.1371\/journal.pone.0121933","article-title":"Dynamic changes in amino acid concentration profiles in patients with sepsis.","volume":"10","author":"Su","year":"2015","journal-title":"PLoS One"},{"key":"R41-20251106","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.2196\/medinform.5909","article-title":"Prediction of sepsis in the intensive care unit with minimal electronic health record data: A machine learning approach.","volume":"4","author":"Desautels","year":"2016","journal-title":"JMIR Medical Informatics"},{"key":"R42-20251106","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s12871-023-02317-4","article-title":"Metabolomics and machine learning approaches for diagnostic and prognostic biomarkers screening in sepsis.","volume":"23","author":"She","year":"2023","journal-title":"BMC Anesthesiol"},{"key":"R43-20251106","doi-asserted-by":"crossref","first-page":"6950576","DOI":"10.1155\/2020\/6950576","article-title":"Machine learning algorithms identify pathogen-specific biomarkers of clinical and metabolomic characteristics in septic patients with bacterial infections.","volume":"2020","author":"Zheng","year":"2020","journal-title":"Biomed Res Int"},{"key":"R44-20251106","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ccm.2016.01.011","article-title":"Metabolism, metabolomics, and nutritional support of patients with sepsis.","volume":"37","author":"Englert","year":"2016","journal-title":"Clin Chest Med"},{"key":"R45-20251106","doi-asserted-by":"crossref","first-page":"e2200112","DOI":"10.1002\/pmic.202200112","article-title":"Portable mass spectrometry system: Instrumentation, applications, and path to \u2019omics analysis.","volume":"22","author":"Wang","year":"2022","journal-title":"Proteomics"},{"key":"R46-20251106","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jama.2009.90","article-title":"Scientists seek to sniff out diseases.","volume":"301","author":"Friedrich","year":"2009","journal-title":"JAMA"},{"key":"R47-20251106","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S2213-2600(17)30294-1","article-title":"Classification of patients with sepsis according to blood genomic endotype: A prospective cohort study.","volume":"5","author":"Scicluna","year":"2017","journal-title":"Lancet Respir Med"},{"key":"R48-20251106","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.immuni.2021.10.012","article-title":"The immunology of sepsis.","volume":"54","author":"van der Poll","year":"2021","journal-title":"Immunity"},{"key":"R49-20251106","doi-asserted-by":"crossref","first-page":"e0197049","DOI":"10.1371\/journal.pone.0197049","article-title":"Integrative omics to detect bacteremia in patients with febrile neutropenia.","volume":"13","author":"Kelly","year":"2018","journal-title":"PLoS One"},{"key":"R50-20251106","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00134-025-07859-4","article-title":"Metabolic septic shock sub-phenotypes, stability over time and association with clinical outcome.","volume":"51","author":"Antcliffe","year":"2025","journal-title":"Intensive Care Med"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001336","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T14:00:21Z","timestamp":1762437621000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":47,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000001336","relation":{},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]}}}